Edge
StocktwitsEarnings

Official STOCKTWITS Representative

$INO Q3 '25 Earnings Results & Recap
In Q3 2025, Inovio reported a net loss of $45.5 million (or $0.87 per share) driven by warrant liability adjustments and expects file acceptance by the FDA by year end for INO-3107 with a potential PDUFA date in mid-2026.Since Post
Advertisement|Remove ads.